Nrx Pharmaceuticals Inc (NRXP) Stock Price, Quote & News

Company Profile

NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder, and chronic pain. Its lead drug candidates include NRX-101, an oral, fixed dosed combination of D-cycloserine and lurasidone for suicidal treatment-resistant bipolar depression in patients with sub-acute suicidal ideation and behavior in phase 2 trial; and NRX-100, a preservative-f...

Industry: Biotechnology

Sector: Healthcare

Phone: 484 254 6134

Website: www.nrxpharma.com

Address:

1201 Orange Street, Suite 600, Wilmington, United States

BlazingStocks Mar. 17 at 7:15 PM

$NRXP - Published results have shown 87% clinical response to non-invasive Transcranial Magnetic Stimulation with neuroplastic medications. https://finance.yahoo.com/news/hope-therapeutics-nrx-subsidiary-nasdaq-110000927.html

0 · Reply

NetworkNewsWire Mar. 17 at 4:41 PM

BioMedNewsBreaks — $NRXP Receives FDA Feedback On Bioequivalence For Ketamine Product https://ibn.fm/fNDMM

1 · Reply

flybyme Mar. 17 at 4:11 PM

$NRXP oh news and it falls as always , except for the surprise yesterday

2 · Reply

SmallCapGrowth Mar. 17 at 3:59 PM

#FrontPageStocks News: NRx Pharmaceuticals (Nasdaq: $NRXP) Announces FDA Bioequivalence Determination by Office of Generic Drugs for NRx’s Preservative-Free Ketamine Application https://youtube.com/shorts/IfM7vckk3SE https://finance.yahoo.com/news/nrx-pharmaceuticals-nasdaq-nrxp-announces-110000223.html @FRONTPAGESTOCKS #StockHighAlert #NRXP #NASDAQ #STOCKS

0 · Reply

jonny80s Mar. 17 at 3:12 PM

$NRXP is the q4 scheduled? Will they get it in before q1 closes?

0 · Reply

BlazingStocks Mar. 17 at 2:46 PM

$NRXP News March 09, 2026 HOPE Therapeutics, an NRx Subsidiary (Nasdaq:NRXP) Announces opening of Palm Beach, FL Clinic offering One Day treatment for Depression and PTSD https://finance.yahoo.com/news/hope-therapeutics-nrx-subsidiary-nasdaq-110000927.html

0 · Reply

IChiGOdoranZ Mar. 17 at 2:39 PM

$NRXP News : NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Bioequivalence Determination by Office of Generic Drugs for NRx’s Preservative-Free Ketamine Application https://ir.nrxpharma.com/news-releases/news-release-details/nrx-pharmaceuticals-nasdaqnrxp-announces-fda-bioequivalence

0 · Reply

Tonyboner Mar. 17 at 2:35 PM

$NRXP No Rush to cover as they need money.

0 · Reply

UltimateTrader_22 Mar. 17 at 2:33 PM

$NRXP NRx Pharmaceuticals (Nasdaq:$NRXP) Announces FDA Bioequivalence Determination by Office of Generic Drugs for NRx’s Preservative-Free Ketamine Application Read More - https://ir.nrxpharma.com/news-releases/news-release-details/nrx-pharmaceuticals-nasdaqnrxp-announces-fda-bioequivalence #PharmaNews #mentalhealth #ketamine #PTSD #bipolar #psychiatry #healthcare #NRxPharma https://x.com/NRxPharma/status/2033864750963335460

0 · Reply

Goldwave9 Mar. 17 at 2:32 PM

$NRXP Could be big mover, but will take some time to recover from that but g. drop today. Should see big results within 3 to 5 days.

1 · Reply

NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Bioequivalence Determination by Office of Generic Drugs for NRx's Preservative-Free Ketamine Application

Mar 16, 2026, 7:00 AM EDT - 1 day ago

NRx Pharmaceuticals (Nasdaq:NRXP) Confirms Path to New Drug Application with Real World Data and Broader Proposed Indication for NRX-100 (ketamine) Following Type C FDA Meeting

Mar 9, 2026, 7:00 AM EDT - 8 days ago

HOPE Therapeutics, an NRx Subsidiary (Nasdaq:NRXP) Announces opening of Palm Beach, FL Clinic offering One Day treatment for Depression and PTSD

Mar 2, 2026, 7:00 AM EST - 15 days ago

NRx Pharmaceuticals (Nasdaq: NRXP) Appoints Prof. Joshua Brown MD, PhD, as Chief Medical Innovation Officer

Feb 17, 2026, 7:00 AM EST - 4 weeks ago

NRx Pharmaceuticals (Nasdaq:NRXP) Announces Path to New Drug Application with Real World Data and Broader Proposed Indication for NRX-100 (ketamine) Following Type C FDA Meeting

Jan 16, 2026, 7:03 AM EST - 2 months ago

NRx Pharmaceuticals (Nasdaq:NRXP) Announces 2025 Annual Meeting Date and Record Date

Jan 14, 2026, 7:03 AM EST - 2 months ago

NRx Pharmaceuticals (Nasdaq:NRXP) Announces 70,000 Patient Data on Real World Use of Ketamine for Treatment of Suicidal Depression to be Submitted to the FDA in Support of NRX-100 Approval

Jan 5, 2026, 6:57 AM EST - 2 months ago

NRx Pharmaceuticals (Nasdaq:NRXP) and neurocare Group AG Announce Joint Offering of Neuroplastic Therapy Targeting Depression, PTSD, and other mental health afflictions

Dec 18, 2025, 7:05 AM EST - 3 months ago

NRx Pharmaceuticals (Nasdaq:NRXP) announces elimination of all balance sheet debt following equity conversion

Dec 3, 2025, 7:00 AM EST - 3 months ago

NRx Pharmaceuticals to discuss new NRX-101 pipeline indication for augmentation of Transcranial Magnetic Stimulation

Dec 2, 2025, 11:23 AM EST - 3 months ago

NRx Pharmaceuticals, Inc. (NRXP) Discusses Regulatory Update and Development Pipeline Expansion for Preservative-Free Ketamine Formulation Transcript

Dec 2, 2025, 8:30 AM EST - 3 months ago

NRx Pharmaceuticals Announces US Food and Drug Administration (FDA) Receipt of ANDA for KETAFREE™, a Preservative-Free IV Ketamine

Dec 2, 2025, 7:30 AM EST - 3 months ago

NRx Pharmaceuticals (NASDAQ: NRXP) and HOPE Therapeutics to Host Corporate Update Call

Dec 1, 2025, 8:03 AM EST - 3 months ago

NRx Pharmaceuticals (NASDAQ:NRXP) and HOPE Therapeutics to Present at NobleCon21 - Noble Capital Markets' Twenty First Annual Emerging Growth Equity Conference

Nov 17, 2025, 11:57 AM EST - 4 months ago

NRx Pharmaceuticals, Inc. (NRXP) Q3 2025 Earnings Call Transcript

Nov 17, 2025, 8:03 AM EST - 4 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Nov 12, 2025, 8:31 AM EST - 4 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Third Quarter 2025 Financial Results on November 17, 2025

Nov 10, 2025, 8:03 AM EST - 4 months ago

HOPE Therapeutics, Inc., an NRx Pharmaceuticals Subsidiary, Announces First-in-Florida Initiation of One Day (ONE-D) Depression Treatment in Partnership with Ampa Health

Oct 20, 2025, 8:03 AM EDT - 5 months ago

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Inclusion of Cohen & Associates, LLC of Sarasota, FL into the HOPE Network and Appointment of Dr. Rebecca Cohen as HOPE Medical Director

Oct 6, 2025, 8:03 AM EDT - 5 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Present at Noble Capital Markets October 2025 Emerging Growth Virtual Equity Conference

Sep 29, 2025, 8:03 AM EDT - 6 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Re-Files Abbreviated New Drug Application (ANDA) for KETAFREE™, Preservative-Free IV Ketamine

Sep 24, 2025, 8:03 AM EDT - 6 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Receives Notification of US Food and Drug Administration Approval of Suitability Petition for NRx's Proposed Strength of Preservative-Free Ketamine

Sep 8, 2025, 8:17 AM EDT - 6 months ago

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Complete the Acquisition of Dura Medical; Initial Acquisition in Network of Interventional Psychiatry Clinics

Sep 3, 2025, 8:03 AM EDT - 6 months ago

NRx Pharmaceuticals (NASDAQ:NRXP) to Participate in a Fireside Chat at H.C. Wainwright's 27th Annual Global Investment Conference on Monday, September 8th

Sep 2, 2025, 1:19 PM EDT - 7 months ago

UPDATE -- NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Selected to Present at the 2025 Global Passion Project with Matthew Rockefeller, Sponsored by Rockefeller Global Family Office

Sep 2, 2025, 8:41 AM EDT - 7 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Selected to Present at the 2025 Global Passion Project with Matthew Rockefeller and Rockefeller Capital

Aug 27, 2025, 8:03 AM EDT - 7 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Expanded Access Policy for NRX-100 (preservative-free ketamine)

Aug 20, 2025, 12:23 PM EDT - 7 months ago

NRx Pharmaceuticals, Inc. (NRXP) Q2 2025 Earnings Call Transcript

Aug 18, 2025, 8:10 AM EDT - 7 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Aug 13, 2025, 6:06 PM EDT - 7 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reschedules Second Quarter 2025 Financial Results Release to August 19, 2025

Aug 11, 2025, 4:05 PM EDT - 7 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Second Quarter 2025 Financial Results on August 14, 2025

Aug 11, 2025, 8:03 AM EDT - 7 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Granted FDA Fast Track Designation for NRX-100 for Suicidal Ideation in Patients with Depression, including Bipolar Depression

Aug 8, 2025, 8:03 AM EDT - 7 months ago

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Receipt of Final Clearance to Proceed to Closing of Dura Medical Acquisition from Florida's Agency for Health Care Administration (AHCA)

Aug 4, 2025, 8:03 AM EDT - 8 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Filing of a Citizen Petition with the US Food and Drug Administration Seeking Removal of Benzethonium Chloride from Ketamine Products

Jul 29, 2025, 8:03 AM EDT - 8 months ago

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Join Fireside Chat at BTIG Virtual Biotech Conference July 29 - 30, 2025

Jun 26, 2025, 8:03 AM EDT - 9 months ago

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Agreement to Acquire Interest in Cohen and Associates, LLC for HOPE's Network of Interventional Psychiatry Clinics

Jun 23, 2025, 8:03 AM EDT - 9 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Filing of Commissioner's National Priority Voucher Application for Intravenous Ketamine (NRX-100)

Jun 16, 2025, 8:03 AM EDT - 9 months ago

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) and HOPE Therapeutics, Inc. Announce Strategic Investor Relations Partnership with astr partners

Jun 12, 2025, 8:03 AM EDT - 9 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) and HOPE Therapeutics, Inc. to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference

Jun 5, 2025, 8:03 AM EDT - 10 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Files Abbreviated New Drug Application (ANDA) for Preservative-Free IV Ketamine

May 16, 2025, 8:46 PM EDT - 10 months ago

NRx Pharmaceuticals, Inc. (NRXP) Q1 2025 Earnings Call Transcript

May 15, 2025, 4:03 PM EDT - 10 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports First Quarter 2025 Financial Results and Provides Corporate Update

May 15, 2025, 10:15 AM EDT - 10 months ago

HOPE Therapeutics, Inc. a subsidiary of NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Signing of Term Sheet for $7.8 Million Debt Financing to Fuel HOPE Clinic Acquisitions

May 13, 2025, 8:03 AM EDT - 11 months ago

HOPE Therapeutics, Inc. and NRx Pharmaceuticals (NASDAQ:NRXP) Announce Signing of Definitive Agreement to Purchase Kadima Neuropsychiatry Institute; Foundational Acquisition for the HOPE Network of Interventional Psychiatry Clinics

May 12, 2025, 8:03 AM EDT - 11 months ago

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Report First Quarter 2025 Financial Results on May 15, 2025

May 6, 2025, 8:03 AM EDT - 11 months ago

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Host Investor Event at Mar-A-Lago Club on May 8, 2025

May 5, 2025, 8:03 AM EDT - 11 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Files Patent Application for NRX-100, its Proprietary, Preservative Free Formulation of IV Ketamine

Apr 30, 2025, 8:46 AM EDT - 11 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces FDA Award of Filing Fee Waiver for Upcoming NRX-100 (preservative free ketamine) New Drug Application to Treat Patients with Suicidal Depression

Apr 21, 2025, 8:01 AM EDT - 11 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) and HOPE Therapeutics™, Inc.to Participate in an H.C. Wainwright @ Home Fireside Discussion on Tuesday, April 22, 2025

Apr 3, 2025, 8:03 AM EDT - 1 year ago

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Signing of a Term Sheet for Strategic Investment from a Global Medical Device Manufacturer into HOPE

BlazingStocks Mar. 17 at 7:15 PM

0 · Reply

NetworkNewsWire Mar. 17 at 4:41 PM

BioMedNewsBreaks — $NRXP Receives FDA Feedback On Bioequivalence For Ketamine Product https://ibn.fm/fNDMM

1 · Reply

flybyme Mar. 17 at 4:11 PM

$NRXP oh news and it falls as always , except for the surprise yesterday

2 · Reply

SmallCapGrowth Mar. 17 at 3:59 PM

0 · Reply

jonny80s Mar. 17 at 3:12 PM

$NRXP is the q4 scheduled? Will they get it in before q1 closes?

0 · Reply

BlazingStocks Mar. 17 at 2:46 PM

0 · Reply

IChiGOdoranZ Mar. 17 at 2:39 PM

0 · Reply

Tonyboner Mar. 17 at 2:35 PM

$NRXP No Rush to cover as they need money.

0 · Reply

UltimateTrader_22 Mar. 17 at 2:33 PM

0 · Reply

Goldwave9 Mar. 17 at 2:32 PM

$NRXP Could be big mover, but will take some time to recover from that but g. drop today. Should see big results within 3 to 5 days.

1 · Reply

SoloBueno Mar. 17 at 2:30 PM

$NRXP For the shareholders' sake, I sure hope this is a win for Javitt. Since the Covid days, he and his social media arm, DavidBG, have done and said whatever it took to keep the doors open... the things they promised, their claims & reach - beyond compare. Everything has failed: partnerships, 100 million run rate, pain data, spin offs, board and CEO departures, financing …..all at the shareholders' expense. They talk a big game - sadly never deliver.

0 · Reply

DARKP00L Mar. 17 at 1:11 PM

$NRXP

1 · Reply

StockNews_Live Mar. 17 at 11:17 AM

$NRXP 🎯 STOCK NEWS ALERT 💵 Price: $2.09 (+11.83%) 🔥 Sentiment Score: 85/100 🚀 VERY POSITIVE NEWS 📄 NRx Pharmaceuticals, Inc. announced that it has received a letter from the Bioequivalence Program of the FDA Office of Generic Drugs stating that “FDA has not identified any bioequivalence… 📎 https://stocknews.live/news/NRXP/n-rx-pharmaceuticals-nasdaq-07951.html

0 · Reply

YoloAlfred Mar. 17 at 11:08 AM

$NRXP added

0 · Reply

DARKP00L Mar. 17 at 11:06 AM

$NRXP 07:02 on Mar. 17 2026 NRx Pharmaceuticals Says FDA Office Of Generic Drugs Found No Bioequivalence Deficiencies At This Time For Preservative-Free Ketamine ANDA, Summer 2026 GDUFA Decision Expected #tradeideas

0 · Reply

Outcomes Mar. 17 at 11:06 AM

$NRXP

0 · Reply

StockNews_Live Mar. 17 at 11:05 AM

0 · Reply

Outcomes Mar. 17 at 11:02 AM

$NRXP https://ir.nrxpharma.com/news-releases/news-release-details/nrx-pharmaceuticals-nasdaqnrxp-announces-fda-bioequivalence

0 · Reply

TheTradeXchange Mar. 17 at 11:02 AM

$NRXP - NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Bioequivalence Determination by Office of Generic Drugs for NRx’s Preservative-Free Ketamine Application

0 · Reply

surfsup11 Mar. 17 at 2:58 AM

$NRXP All depression meds on market increase suicidal ideation. This one does not. FDA seems to like it. You be the judge.

0 · Reply

jonny80s Mar. 17 at 12:53 AM

$NRXP how’s everybody liking the 500% dilution we’ve seen over the last 3 years?

2 · Reply

FounderV Mar. 17 at 12:20 AM

$NRXP This is just the beginning...

2 · Reply

Market Cap	59.28M
Revenue (ttm)	0.00
Net Income (ttm)	-25.13M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	14.31
Profit Margin	0.00%
Debt to Equity Ratio	-0.39

Volume	934,948
Avg Vol	1,084,370
Day's Range	N/A - N/A
Shares Out	31.87M
Stochastic %K	75%
Beta	1.97
Analysts	Strong Sell
Price Target	$38.00